Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Security class unavailable · CUSIP: 69353Y103
Event date: 2020-09-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,641,840
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-008767
- Form type
- SC 13G
- Filer
- PMV Pharmaceuticals, Inc.
- CIK
- CIK 1699382
- Filed
- Oct 05, 2020
- Reporting period
- Sep 25, 2020
- Description
- Schedule 13G beneficial ownership